CoChat
Sign Up
Cited by 120Attention Deficit Hyperactivity DisorderTraffic and Road SafetyPharmaceutical studies and practices

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Impact of Methylphenidate Delivery Profiles on Driving Performance of Adolescents With Attention-Deficit/Hyperactivity Disorder: A Pilot Study

Cox, Daniel J., Merkel, R Lawrence, Penberthy, Jennifer Kim, Kovatchev, Boris, Hankin, Cheryl S.·2004·Journal of the American Academy of Child & Adolescent Psychiatry
DOI 10.1097/00004583-200403000-00007
Open this paper in CoChat — free account

Abstract

Objective Adolescents with attention-deficit/hyperactivity disorder (ADHD) are at high risk for driving accidents. One dose of methylphenidate (MPH) improves simulator driving performances of ADHD-diagnosed adolescents at 1.5 hours post-dose. However, little is known about the effects of different MPH delivery profiles on driving performance throughout the day.Method This randomized, crossover, single-blind study compared osmotic, controlled-release oral system (OROS) MPH (Concerta) given q.d. to immediate-release MPH (Ritalin) given in equal doses t.i.d. on driving performance among six male ADHD-diagnosed adolescent drivers aged 16 to 19 years. Under each treatment condition, participants were maintained on their medication dosage for 7 days, then drove a sophisticated driving simulator at 2 p.m., 5 p.m., 8 p.m., and 11 p.m. The primary outcome measure was each participant's computer-quantified Impaired Driving Score (IDS).Results IDS worsened in the evenings for participants receiving MPH t.i.d. but remained stable when they received once-daily OROS MPH. Participants performed significantly better when receiving OROS MPH q.d. compared with MPH t.i.d. (F = 9.3, df = 1, p =.004). When MPH was given t.i.d., IDS significantly worsened beginning at 8 p.m. compared to OROS MPH (p =.01).Conclusions Participants demonstrated significantly less variability and better driving performance when receiving OROS MPH q.d. compared to MPH t.i.d., particularly in the evenings.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004583-200403000-00007

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Cox, 2002, Specific driving impairments with progressive age, Adv Med Psychother Psychodiag, 11, 107
  2. Guerrier JH, Cox DJ (in press), The validity of a low-cost driving simulator in assessing driving performance. Proc Hum Factors Ergonom Soc

Cited by

Sorted by citations

Items 101–119 of 119

Related

See all

Metadata

Authors
Cox, D. J., Merkel, R. L., Penberthy, J. K., Kovatchev, B., & Hankin, C. S.
Affiliations
University of Virginia Health System (US)
Corresponding author
Cox, Daniel J.
ORCID
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2004-03
Volume
43
Issue
3
Pages
269-275
ISSN
0890-8567 (ISSN-L)
DOI
10.1097/00004583-200403000-00007
OpenAlex
W2010345730
Cited by
120
References
31
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 3 · 2013: 6 · 2012: 6
FWCI
10.09
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
methylphenidate, attention deficit hyperactivity disorder, adolescents, driving performance, impaired driving, osmotic-release oral system, controlled-release formulation, immediate-release formulation, dosing frequency, driving simulator
MeSH terms
Adolescent, Adult, Central Nervous System Stimulants, Analysis of Variance, Attention Deficit Disorder with Hyperactivity, Automobile Driving, Delayed-Action Preparations, Humans, Male, Methylphenidate, Pilot Projects, Single-Blind Method, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review